|
Market Closed -
Nasdaq Stockholm
01:00:00 2026-10-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 174.80 SEK | +2.34% |
|
+5.94% | +11.20% |
| Oct. 28 | Calendar Thursday, October 29 | FW |
| Oct. 26 | CellaVision expected to report SEK57m EBITDA, FactSet | FW |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 4,169 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | 11.2% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 3,980 | 3,939 | 3,881 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | 10.95% | -1.02% | -1.47% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 30x | 23.3x | 20.5x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 4.31x | 3.9x | 3.5x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -3.2x | 0.8x | 1.5x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 5.33x | 4.74x | 4.38x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 5.09x | 4.48x | 4.08x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 17.5x | 13.8x | 12.2x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 22.6x | 17.3x | 14.9x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 36.2x | 32.5x | 26.9x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 2.76% | 3.07% | 3.71% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.223 | 3.53 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 1.57% | 1.84% | 2.02% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 5.819 | 7.514 | 8.52 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 47.3% | 42.9% | 41.4% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 781.5 | 878.9 | 952 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 227.5 | 285.8 | 318.4 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 176 | 228.1 | 260.3 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 138.7 | 181.4 | 205.9 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -189.5 | -230 | -288.1 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 174.80 | 174.80 | 174.80 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 2/4/22 | 2/8/23 | 2/7/24 | 2/6/25 | 2/5/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.35x | 4.97x | 17.07x | 1.61% | 410M | |
| 35.52x | 6x | 23.03x | 0.27% | 256B | |
| 36.88x | 7x | 21.91x | 0.62% | 163B | |
| 51.4x | 12.45x | 26.72x | -.--% | 155B | |
| 17.1x | 3.39x | 11.04x | -.--% | 65.3B | |
| 36x | 7.21x | 22.79x | -.--% | 52.35B | |
| 20.51x | 2.46x | 12.42x | 2.46% | 51.93B | |
| 47.99x | 11.84x | 26.1x | -.--% | 50.75B | |
| 34.58x | 6.85x | 23.26x | 0.58% | 50.04B | |
| 82.02x | 7.79x | 23.64x | -.--% | 46.03B | |
| Average | 39.14x | 7.00x | 20.80x | 0.55% | 89.08B | |
| Weighted average by Cap. | 39.38x | 7.45x | 22.17x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
